National Wear Red Day is a day in February when many people wear red to show their support for the awareness of heart disease.
National Wear Red Day is a day in February when many people wear red to show their support for the awareness of heart disease.
In the US, National Wear Red Day occurs on the first Friday in February each year. [1]
National Wear Red Day is sponsored by The Heart Truth , under the auspices of the National Heart, Lung, and Blood Institute—part of the National Institutes of Health, U.S. Department of Health and Human Services. The Heart Truth is a national awareness campaign for women about heart disease. The Heart Truth created and introduced the Red Dress as the national symbol for women and heart disease awareness in 2002. The goal is to warn women of their #1 health threat. [2]
In the UK, Wear Red Day is held on the first Friday of February. It's organised by Yorkshire-based charity Children's Heart Surgery Fund to raise awareness of congenital heart disease. [3]
The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.
The National Heart, Lung, and Blood Institute (NHLBI) is the third largest Institute of the National Institutes of Health, located in Bethesda, Maryland, United States. It is tasked with allocating about $3.6 billion in FY 2020 in tax revenue to advancing the understanding of the following issues: development and progression of disease, diagnosis of disease, treatment of disease, disease prevention, reduction of health care disparities within the American population, and advancing the effectiveness of the US medical system. NHLBI's Director is Gary H. Gibbons (2012–present).
Raynaud syndrome, also known as Raynaud's phenomenon, is a medical condition in which the spasm of small arteries causes episodes of reduced blood flow to end arterioles. Typically, the fingers, and less commonly, the toes, are involved. Rarely, the nose, ears, nipples, or lips are affected. The episodes classically result in the affected part turning white and then blue. Often, numbness or pain occurs. As blood flow returns, the area turns red and burns. The episodes typically last minutes but can last several hours. The condition is named after the physician Auguste Gabriel Maurice Raynaud, who first described it in his doctoral thesis in 1862.
Cardiac surgery, or cardiovascular surgery, is surgery on the heart or great vessels performed by cardiac surgeons. It is often used to treat complications of ischemic heart disease ; to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditis, rheumatic heart disease, and atherosclerosis. It also includes heart transplantation.
The orange ribbon is a symbol adopted for a very wide variety of uses in different places.
A vascular bypass is a surgical procedure performed to redirect blood flow from one area to another by reconnecting blood vessels. Often, this is done to bypass around a diseased artery, from an area of normal blood flow to another relatively normal area. It is commonly performed due to inadequate blood flow (ischemia) caused by atherosclerosis, as a part of organ transplantation, or for vascular access in hemodialysis. In general, someone's own vein (autograft) is the preferred graft material for a vascular bypass, but other types of grafts such as polytetrafluoroethylene (Teflon), polyethylene terephthalate (Dacron), or a different person's vein (allograft) are also commonly used. Arteries can also serve as vascular grafts. A surgeon sews the graft to the source and target vessels by hand using surgical suture, creating a surgical anastomosis.
Bernadine Patricia Healy was an American cardiologist and the first female director of the National Institutes of Health (NIH).
The Dietary Approaches to Stop Hypertension or the DASH diet is a diet to control hypertension promoted by the U.S.-based National Heart, Lung, and Blood Institute, part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services. The DASH diet is rich in fruits, vegetables, whole grains, and low-fat dairy foods. It includes meat, fish, poultry, nuts, and beans, and is limited in sugar-sweetened foods and beverages, red meat, and added fats. In addition to its effect on blood pressure, it is designed to be a well-balanced approach to eating for the general public. DASH is recommended by the United States Department of Agriculture (USDA) as a healthy eating plan. The DASH diet is one of three healthy diets recommended in the 2015–20 U.S. Dietary Guidelines, which also include the Mediterranean diet and a vegetarian diet. The American Heart Association (AHA) considers the DASH diet "specific and well-documented across age, sex and ethnically diverse groups."
Elizabeth Nabel is an American cardiologist and Executive Vice President of Strategy at ModeX Therapeutics and OPKO Health. Prior to this role, she served as President of Brigham Health and its Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School, and Director of the NIH's National Heart, Lung, and Blood Institute.
The Heart Truth is a campaign meant to raise awareness of the risk of heart disease in women. The campaign is sponsored in the United States by the National Heart, Lung, and Blood Institute, an organization of the United States Department of Health and Human Services; a similar campaign is promoted in Canada by the Heart and Stroke Foundation of Canada. It focuses mainly on educating women aged forty to sixty, as that is the time when the risk of heart disease begins to increase.
November is National Chronic Obstructive Pulmonary Disease (COPD) Awareness Month. Sponsored by the US COPD Coalition, the observance is a time for organizations and communities across the country to increase the overall awareness of COPD. COPD Learn More Breathe Better, the title of the National Heart, Lung, and Blood Institute’s national awareness and education campaign, has again been adopted as the theme for the most recent National COPD Awareness Month.
Carmen Marc Valvo is an American designer who specializes in evening wear and high-end cocktail dresses for a line of the same name, founded in 1989. He also has an eyewear collection, a lingerie collection, a swimsuit line which is a best-seller at Victoria's Secret, and a Hamptons-inspired home collection, called CMV Home sold through QVC. He most recently launched a collection of evening bags and an exclusive Bridal Collection, in 2010. Valvo is best known for his tailored fit and form-fitting dresses.
Susan Shurin is a senior adviser at the National Cancer Institute. From 2006–2014, she served as Deputy and Acting Director of the National Heart, Lung, and Blood Institute at the National Institutes of Health.
The Rare Diseases Clinical Research Network (RDCRN) is an initiative of the US Office of Rare Diseases Research (ORDR). RDCRN is funded by the ORDR, the National Center for Advancing Translational Sciences and collaborating institute centers. The RDCRN is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.
Clarice D. Reid is an American pediatrician born in Birmingham, Alabama, who led the National Sickle Cell Disease Program at the U.S. National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health. She went on to become the Director of Division of Blood Diseases and Resources at NHLBI. Reid was a member of the 1985-1986 Taskforce on Black and Minority Health. She has also served as President Emeritus on the American Bridge Association's Education and Charitable Foundation, and has scored a rare perfect bridge score.
The Atherosclerosis Risk in Communities (ARIC) Study is a multi-site, prospective, biracial cohort study funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. The ARIC Study was designed to investigate the etiology and clinical outcomes of atherosclerosis. A total of 15,792 middle-aged men and women were enrolled from four U.S. communities:
Martha Vaughan was an American biochemist at the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) in Bethesda, Maryland. She holds the title of emeritus scientist in the Laboratory of Metabolic Regulation and previously served as chief of NHLBI’s Laboratory of Cellular Metabolism. At the NIH, much of her work has focused on cell signaling, cellular regulation, lipid metabolism, and the identification of key proteins associated with cholera toxin and pertussis toxin. Vaughan first came to the NIH in the agency’s fledgling National Heart Institute, now NHLBI, and with the title of senior assistant surgeon worked on protein synthesis in the Building 3 laboratory of biochemist and public scientist Christian B. Anfinsen, Ph.D., who went on to share the 1972 Nobel Prize in Chemistry
James M. Anderson is an American Professor of Medicine and Cell Biology and is a Chief of Section of Digestive Diseases at the Yale School of Medicine. Anderson is also a director of the Division of Program Coordination, Planning, and Strategic Initiatives at the National Institutes of Health.
The Strong Heart Study is an ongoing cohort study of cardiovascular disease (CVD) and its risk factors among American Indian men and women. The original cohort began in 1984 with 4,549 participants ages 35–74 from 13 tribal nations and communities in Arizona, Oklahoma, North Dakota, and South Dakota. The need for specific ethnic and cultural understanding and sensitivities was recognized from the onset, so the study has a community-based participatory research (CBPR) model. Community members were involved in all stages of conception, design, and implementation of the research. Now in its seventh phase, the extensive research has led to many important findings about heart disease and unique risk factors in native populations. It is a project funded by the National Heart, Lung, and Blood Institute (NHLBI). The study maintains field centers in Oklahoma, North and South Dakota, and Arizona and a coordinating center at the University of Oklahoma Health Sciences Center.
Michael S. Lauer is an American cardiologist and physician-scientist. He is the deputy director for extramural research at the National Institutes of Health (NIH).